Children in 2077: Designing Children’s Technologies in the Age of Transhumanism

What for and how will we design children’s technologies in the transhumanism age, and what stance will we take as designers? This paper aims to answer this question with 13 fictional abstracts from sixteen authors of different countries, institutions and disciplines. Transhumanist thinking envisions enhancing human body and mind by blending human biology with technological augmentations. Fundamentally, it seeks to improve the human species, yet the impacts of such movement are unknown and the implications on children’s lives and technologies were not explored deeply. In an age, where technologies can clearly be defined as transhumanist, such as under-skin chips or brain-machine interfaces, our aim is to reveal probable pitfalls and benefits of those technologies on children’s’ lives by using the power of design fiction

Education in the knowledge society : EKS

Resumen basado en el de la publicaciónTítulo, resumen y palabras clave también en españolLa discapacidad en el aprendizaje está asociada con la incapacidad para hablar, escuchar, razonar, leer o escribir o con los problemas con las habilidades aritméticas y matemáticas; además, su prevalencia ha aumentado notablemente entre los niños en edad escolar, especialmente en los últimos años. Se analiza la situación en 2019 y las tendencias en la investigación sobre la discapacidad en el aprendizaje a través del análisis de contenidos. Se utiliza el análisis de contenido como método de investigación cualitativa. Los datos del estudio se obtienen de Web of Science utilizando las palabras clave “learning disability”. Para analizar los datos obtenidos se utilizan criterios de análisis de contenido previamente determinados.ES

Effects of thymosin alpha-1 on erythrocyte lipid levels and erythrocyte membrane (Na+-K+)-ATPase activity in experimental hypercholesterolemia

Thymosin alpha-1 is an active polypeptide isolated from thymus. This polypeptide is widely used in the diagnosis and treatment of many diseases, especially immune diseases. In this present study, we examined the effects of thymosin alpha-1 on plasma and erythrocyte lipid levels and the changes in erythrocyte membrane (Na+, K+)ATPase activity in hypercholesterolemic rabbits. The erythrocyte lipid levels decreased, whereas the erythrocyte membrane (Na+, K+)ATPase activity increased significantly in these rabbits after thymosin alpha-1 injection. These findings suggest that thymosin alpha-1 is effective on both the lipid level and erythrocyte membrane (Na+, K+)ATPase activity

COMPARISON OF INTRAPLEURAL VERSUS INTRAVENOUS MORPHINE FOR POSTTHORACOTOMY PAIN MANAGEMENT

Objective: To compare the analgesic effects of intrapleural and intravenous morphine administration for postthoracotomy pain management

Thymosin alpha (1) protects liver and aorta from oxidative damage in atherosclerotic rabbits

The thymus hormones were reported to be effective on lipid peroxidation and the antioxidant system. Thymus plays a broader role than just regulating the immune system. Thymosin alpha(1) is the first subgroup extracted from thymosin F5 and has higher biological activity than thymosin F5. In the present study, we have examined the effects of thymosin alpha(1) on lipid levels and lipid peroxidation and glutathione (GSH) content in the plasma, liver and aorta tissues of atherosclerotic rabbits. At the end of thymosin alpha(1) treatment, we determined the lipid levels and lipid peroxidation of the plasma, liver and aorta tissues and hepatic subcellular fractions in these rabbits. Our results demonstrated that thymosin alpha(1) might normalize changed lipid levels and increased lipid peroxides and also elevate decreased GSH in the plasma, liver and aorta tissues of atherosclerotic rabbits. Results of this study suggest that thymosin alpha(1) may be beneficial to prevent and/or to treat atherosclerosis